AstraZeneca_NNP Annual_JJ Report_NNP and_CC Financial_NNP Statements_NNP 90_CD Form_NN 20-F_JJ Information_NN 2003_CD Notes_NNS to_TO the_DT Financial_NNP Statements_NNP continued_VBD 29_CD Post-retirement_NN benefits_NNS Pensions_NNP Background_NNP The_NNP Group_NNP continues_VBZ to_TO account_VB for_IN pension_NN costs_NNS in_IN its_PRP$ primary_JJ Financial_NNP Statements_NNP in_IN accordance_NN with_IN the_DT UK_NNP Statement_NNP of_IN Standard_NNP Accounting_NNP Practice_NNP No._NN ._.
In_IN addition_NN ,_, disclosures_NNS have_VBP been_VBN presented_VBN below_IN in_IN accordance_NN with_IN Financial_NNP Reporting_NNP Standard_NNP No._NN ._.
The_DT Company_NN and_CC most_JJS of_IN its_PRP$ subsidiaries_NNS offer_VBP retirement_NN plans_NNS which_WDT cover_VBP the_DT majority_NN of_IN employees_NNS in_IN the_DT Group_NNP ._.
Many_JJ of_IN these_DT plans_NNS are_VBP defined_VBN contribution_NN where_WRB the_DT company_NN contribution_NN and_CC resulting_VBG profit_NN and_CC loss_NN account_NN charge_NN is_VBZ fixed_VBN at_IN a_DT set_VBN level_NN or_CC is_VBZ a_DT set_NN percentage_NN of_IN employees_NNS pay_VBP ._.
However_RB ,_, several_JJ plans_NNS ,_, mainly_RB in_IN the_DT UK_NNP ,_, US_NNP and_CC Sweden_NNP ,_, are_VBP defined_VBN benefit_NN ,_, where_WRB benefits_NNS are_VBP based_VBN on_IN employees_NNS length_NN of_IN service_NN and_CC final_JJ pensionable_JJ pay_NN ._.
All_DT of_IN the_DT major_JJ plans_NNS are_VBP funded_VBN through_IN legally_RB separate_JJ trustee_NN administered_VBN funds_NNS ._.
The_DT major_JJ defined_VBN benefit_NN plans_NNS ,_, apart_RB from_IN the_DT Swedish_NNP plan_NN ,_, have_VBP been_VBN closed_VBN to_TO new_JJ entrants_NNS since_IN 2000_CD ._.
The_DT cash_NN funding_NN of_IN the_DT plans_NNS ,_, which_WDT may_MD from_IN time_NN to_TO time_NN involve_VB special_JJ payments_NNS ,_, is_VBZ designed_VBN ,_, in_IN consultation_NN with_IN independent_JJ qualified_JJ actuaries_NNS ,_, to_TO ensure_VB that_IN present_JJ and_CC future_JJ contributions_NNS should_MD be_VB sufficient_JJ to_TO meet_VB future_JJ liabilities_NNS ._.
SSAP_NNP 24_CD The_DT cost_NN of_IN defined_VBN benefit_NN plan_NN pensions_NNS in_IN a_DT year_NN can_MD notionally_RB be_VB divided_VBN into_IN the_DT regular_JJ cost_NN and_CC variations_NNS from_IN the_DT regular_JJ cost_NN ._.
Under_IN SSAP_NNP 24_CD the_DT regular_JJ cost_NN is_VBZ based_VBN on_IN actuarial_JJ assumptions_NNS and_CC charged_VBN to_TO the_DT profit_NN and_CC loss_NN account_NN in_IN the_DT year_NN it_PRP is_VBZ incurred_VBN whilst_IN any_DT variations_NNS ,_, which_WDT arise_VBP where_WRB the_DT experience_NN of_IN the_DT scheme_NN varies_VBZ from_IN the_DT assumptions_NNS made_VBN by_IN the_DT actuary_NN ,_, are_VBP charged_VBN or_CC credited_VBN over_IN the_DT estimated_VBN remaining_VBG service_NN lives_NNS of_IN the_DT employees_NNS ._.
Costs_NNS of_IN defined_VBN contribution_NN plan_NN pensions_NNS are_VBP charged_VBN to_TO the_DT profit_NN and_CC loss_NN account_NN immediately_RB ._.
On_IN these_DT bases_NNS ,_, the_DT total_JJ pension_NN cost_NN for_IN the_DT Group_NNP under_IN SSAP_NNP 24_CD for_IN 2003_CD was_VBD $_$ 272m_CD 2002_CD $_$ 220m_CD ,_, 2001_CD $_$ 194m_CD ._.
In_IN the_DT Group_NNP balance_NN sheet_NN at_IN 31_CD December_NNP 2003_CD ,_, accrued_VBN pension_NN costs_NNS included_VBD in_IN other_JJ creditors_NNS amounted_VBD to_TO $_$ 143m_CD 2002_CD $_$ 53m_CD :_: prepaid_JJ pension_NN costs_NNS of_IN $_$ 628m_CD 2002_CD $_$ 268m_CD are_VBP included_VBN in_IN debtors_NNS ._.
Provisions_NNS for_IN unfunded_JJ pension_NN obligations_NNS ,_, included_VBD in_IN provisions_NNS ,_, amounted_VBD to_TO $_$ 283m_CD 2002_CD $_$ 235m_CD ._.
With_IN regard_NN to_TO the_DT Groups_NNS main_JJ UK_NNP defined_VBD benefit_NN fund_NN ,_, the_DT latest_JJS actuarial_JJ valuation_NN was_VBD carried_VBN out_RP at_IN 31_CD March_NNP 2003_CD and_CC the_DT pension_NN cost_NN assessed_VBN using_VBG the_DT projected_VBN unit_NN credit_NN method_NN ._.
The_DT key_JJ accounting_NN assumptions_NNS for_IN the_DT purposes_NNS of_IN SSAP_NNP 24_CD were_VBD that_IN ,_, against_IN a_DT background_NN of_IN long_JJ term_NN UK_NNP price_NN inflation_NN averaging_VBG 2.4_CD %_NN pa_NN ,_, investment_NN returns_NNS would_MD average_VB 6.6_CD %_NN pa_NN ,_, salary_NN increases_NNS 3.7_CD %_NN pa_NN and_CC pension_NN increases_NNS 2.4_CD %_NN pa._NN ._.
The_DT market_NN value_NN of_IN the_DT funds_NNS assets_NNS at_IN the_DT valuation_NN date_NN was_VBD 2,043_CD m_NN $_$ 3,640_CD m_NN equivalent_NN ,_, representing_VBG 89.1_CD %_NN of_IN the_DT liabilities_NNS using_VBG these_DT assumptions_NNS ._.
The_DT cost_NN for_IN accounting_NN purposes_NNS equates_VBZ to_TO 21.1_CD %_NN of_IN pensionable_JJ salaries_NNS ._.
At_IN the_DT same_JJ time_NN ,_, the_DT valuation_NN was_VBD carried_VBN out_RP for_IN ongoing_JJ funding_NN purposes_NNS ,_, with_IN assumptions_NNS slightly_RB more_RBR conservative_JJ than_IN those_DT used_VBN for_IN SSAP_NNP 24_CD purposes_NNS ._.
The_DT market_NN value_NN of_IN the_DT funds_NNS assets_NNS at_IN the_DT valuation_NN date_NN represents_VBZ 87.4_CD %_NN of_IN the_DT liabilities_NNS on_IN a_DT funding_NN basis_NN ._.
The_DT Company_NN had_VBD indicated_VBN to_TO the_DT trustee_NN of_IN the_DT UK_NNP fund_NN its_PRP$ intention_NN to_TO target_VB a_DT solvency_NN ratio_NN of_IN 91_CD %_NN following_VBG the_DT March_NNP 2003_CD actuarial_JJ valuation_NN ,_, and_CC this_DT has_VBZ been_VBN exceeded_VBN with_IN a_DT $_$ 165m_CD cash_NN contribution_NN in_IN 2003_CD ._.
At_IN the_DT time_NN the_DT contribution_NN was_VBD made_VBN in_IN November_NNP ,_, the_DT solvency_NN ratio_NN was_VBD 95_CD %_NN ._.
The_DT longer_JJR term_NN aim_NN is_VBZ to_TO restore_VB solvency_NN over_IN a_DT period_NN of_IN around_IN 15_CD years_NNS ._.
Any_DT cash_NN contributions_NNS made_VBD to_TO the_DT fund_NN are_VBP treated_VBN as_IN prepayments_NNS and_CC taken_VBN into_IN account_NN in_IN the_DT actuarially_RB assessed_VBN contributions_NNS to_TO the_DT fund_NN charged_VBN to_TO the_DT profit_NN and_CC loss_NN account_NN ._.
The_DT US_NNP defined_VBD benefits_NNS program_NN was_VBD actuarially_RB revalued_VBN at_IN 31_CD December_NNP 2003_CD when_WRB plan_NN obligations_NNS were_VBD estimated_VBN to_TO amount_VB to_TO $_$ 925m_CD and_CC plan_NN assets_NNS were_VBD $_$ 1,079_CD m._FW The_DT US_NNP typically_RB makes_VBZ contributions_NNS to_TO mitigate_VB for_IN plan_NN benefit_VBP deficits_NNS on_IN a_DT regular_JJ basis_NN ._.
The_DT Swedish_JJ defined_VBN benefits_NNS program_NN was_VBD actuarially_RB revalued_VBN at_IN 31_CD December_NNP 2003_CD when_WRB plan_NN obligations_NNS were_VBD estimated_VBN to_TO amount_VB to_TO $_$ 440m_CD and_CC plan_NN assets_NNS were_VBD $_$ 441m_CD ._.
AstraZeneca_NNP Annual_JJ Report_NNP and_CC Financial_NNP Statements_NNP Form_NN 20-F_NNP Information_NNP 2003_CD 91_CD 29_CD Post-retirement_NN benefits_NNS continued_VBD Post-retirement_JJ benefits_NNS other_JJ than_IN pensions_NNS In_IN the_DT US_NNP ,_, and_CC to_TO a_DT lesser_JJR extent_NN in_IN some_DT other_JJ countries_NNS ,_, AstraZenecas_NNP employment_NN practices_NNS include_VBP the_DT provision_NN of_IN healthcare_NN and_CC life_NN insurance_NN benefits_NNS for_IN retired_VBN employees_NNS ._.
Some_DT 5,478_CD retired_VBN employees_NNS and_CC covered_VBD dependants_NNS currently_RB benefit_VBP from_IN these_DT provisions_NNS and_CC some_DT 14,176_CD current_JJ employees_NNS will_MD be_VB eligible_JJ on_IN retirement_NN ._.
AstraZeneca_NNP accrues_VBZ for_IN the_DT present_JJ value_NN of_IN such_JJ retiree_NN obligations_NNS over_IN the_DT working_VBG life_NN of_IN the_DT employee_NN ._.
The_DT cost_NN of_IN post-retirement_JJ benefits_NNS other_JJ than_IN pensions_NNS for_IN the_DT Group_NNP in_IN 2003_CD was_VBD $_$ 10m_CD 2002_CD $_$ 22m_CD ,_, 2001_CD $_$ 16m_CD ._.
Provisions_NNS and_CC creditors_NNS set_VBN aside_RB for_IN the_DT benefit_NN obligations_NNS at_IN 31_CD December_NNP 2003_CD amounted_VBD to_TO $_$ 28m_CD 2002_CD $_$ 32m_CD ,_, 2001_CD $_$ 248m_CD ._.
Other_JJ than_IN these_DT provisions_NNS and_CC creditors_NNS there_EX were_VBD plan_NN assets_NNS amounting_VBG to_TO $_$ 194m_CD in_IN the_DT US_NNP at_IN 31_CD December_NNP 2003_CD ._.
These_DT benefit_NN plans_NNS have_VBP been_VBN included_VBN in_IN the_DT disclosure_NN of_IN post-retirement_JJ benefits_NNS under_IN FRS_NNP 17_CD ._.
FRS_NNP 17_CD Full_NNP implementation_NN of_IN FRS_NNP 17_CD had_VBD originally_RB been_VBN intended_VBN for_IN accounting_NN periods_NNS ending_VBG on_IN or_CC after_IN 22_CD June_NNP 2003_CD but_CC has_VBZ been_VBN deferred_VBN by_IN the_DT Accounting_NNP Standards_NNP Board_NNP until_IN accounting_NN periods_NNS commencing_VBG on_IN or_CC after_IN 1_CD January_NNP 2005_CD ._.
However_RB ,_, the_DT requirements_NNS for_IN disclosure_NN under_IN FRS_NNP 17_CD between_IN its_PRP$ issue_NN and_CC full_JJ implementation_NN dates_NNS remain_VBP and_CC this_DT information_NN is_VBZ set_VBN out_RP below_IN ._.
When_WRB fully_RB adopted_VBN ,_, the_DT objective_NN of_IN FRS_NNP 17_CD is_VBZ to_TO reflect_VB the_DT fair_JJ value_NN of_IN post-retirement_JJ plan_NN assets_NNS and_CC liabilities_NNS and_CC associated_VBN charges_NNS in_IN the_DT Financial_NNP Statements_NNP ._.
FRS_NNP 17_CD specifies_VBZ how_WRB key_JJ assumptions_NNS should_MD be_VB formulated_VBN and_CC applied_VBN :_: these_DT assumptions_NNS are_VBP often_RB different_JJ to_TO the_DT funding_NN bases_NNS established_VBN by_IN the_DT pension_NN funds_NNS trustees_NNS or_CC actuaries_NNS ._.
The_DT accounting_NN requirements_NNS of_IN FRS_NNP 17_CD are_VBP broadly_RB as_IN follows_VBZ :_: Post-retirement_NN scheme_NN assets_NNS are_VBP valued_VBN at_IN market_NN values_NNS at_IN the_DT balance_NN sheet_NN date_NN :_: Post-retirement_NN scheme_NN liabilities_NNS are_VBP measured_VBN using_VBG a_DT projected_VBN unit_NN method_NN and_CC discounted_VBN at_IN the_DT current_JJ rate_NN of_IN return_NN on_IN high_JJ quality_NN corporate_JJ bonds_NNS of_IN equivalent_JJ term_NN and_CC currency_NN to_TO the_DT liability_NN :_: and_CC The_DT movement_NN in_IN the_DT scheme_NN surplus_NN deficit_NN excluding_VBG contributions_NNS will_MD be_VB split_VBN between_IN operating_NN charges_NNS and_CC financing_NN items_NNS in_IN the_DT profit_NN and_CC loss_NN account_NN and_CC ,_, in_IN the_DT statement_NN of_IN total_JJ recognized_VBN gains_NNS and_CC losses_NNS ,_, actuarial_JJ gains_NNS and_CC losses_NNS ._.
Financial_NNP assumptions_NNS Qualified_VBN independent_JJ actuaries_NNS have_VBP updated_VBN the_DT actuarial_JJ valuations_NNS of_IN the_DT major_JJ defined_VBN benefit_NN schemes_NNS operated_VBN by_IN the_DT Group_NNP to_TO 31_CD December_NNP 2003_CD ._.
The_DT assumptions_NNS used_VBN by_IN the_DT actuaries_NNS are_VBP the_DT best_JJS estimates_NNS chosen_VBN from_IN a_DT range_NN of_IN possible_JJ actuarial_JJ assumptions_NNS which_WDT ,_, due_JJ to_TO the_DT long_JJ term_NN nature_NN of_IN the_DT scheme_NN ,_, may_MD not_RB necessarily_RB be_VB borne_VBN out_RP in_IN practice_NN ._.
These_DT assumptions_NNS were_VBD as_IN follows_VBZ :_: 2003_CD 2002_CD Rest_VB of_IN Rest_VB of_IN UK_NNP Group_NNP UK_NNP Group_NNP Inflation_NN assumption_NN 2.6_CD %_NN 2.3_CD %_NN 2.2_CD %_NN 2.1_CD %_NN Rate_NN of_IN increase_NN in_IN salaries_NNS 3.9_CD %_NN 4.3_CD %_NN 4.0_CD %_NN 4.0_CD %_NN Rate_NN of_IN increase_NN in_IN pensions_NNS in_IN payment_NN 2.6_CD %_NN 0.6_CD %_NN 2.2_CD %_NN 0.5_CD %_NN Discount_NNP rate_NN 5.4_CD %_NN 5.3_CD %_NN 5.6_CD %_NN 5.8_CD %_NN Long_JJ term_NN rate_NN of_IN return_NN expected_VBN at_IN 31_CD December_NNP Equities_NNPS 8.3_CD %_NN 8.7_CD %_NN 8.3_CD %_NN 8.4_CD %_NN Bonds_NNS 5.1_CD %_NN 5.8_CD %_NN 4.9_CD %_NN 6.1_CD %_NN Others_NNS 4.2_CD %_NN 3.9_CD %_NN 3.7_CD %_NN 3.6_CD %_NN AstraZeneca_NNP Annual_JJ Report_NNP and_CC Financial_NNP Statements_NNP 92_CD Form_NN 20-F_JJ Information_NN 2003_CD Notes_NNS to_TO the_DT Financial_NNP Statements_NNP continued_VBD 29_CD Post-retirement_NN benefits_NNS continued_VBD Post-retirement_JJ scheme_NN deficit_NN The_DT post-retirement_JJ scheme_NN deficit_NN set_VBN out_RP below_IN under_IN FRS_NNP 17_CD is_VBZ as_IN if_IN this_DT standard_NN were_VBD fully_RB applied_VBN ._.
However_RB ,_, under_IN the_DT current_JJ accounting_NN methodology_NN SSAP_NNP 24_CD there_EX are_VBP prepayments_NNS and_CC provisions_NNS including_VBG deferred_JJ tax_NN within_IN the_DT balance_NN sheet_NN at_IN 31_CD December_NNP 2003_CD that_WDT must_MD be_VB taken_VBN into_IN account_NN in_IN calculating_VBG the_DT effect_NN on_IN net_JJ assets_NNS of_IN this_DT deficit_NN in_IN the_DT event_NN of_IN a_DT restatement_NN under_IN FRS_NNP 17_CD ._.
The_DT assets_NNS and_CC liabilities_NNS of_IN the_DT major_JJ defined_VBN benefit_NN schemes_NNS operated_VBN by_IN the_DT Group_NNP at_IN 31_CD December_NNP 2003_CD as_IN calculated_VBN in_IN accordance_NN with_IN FRS_NNP 17_CD are_VBP shown_VBN below_IN ._.
The_DT fair_JJ values_NNS of_IN the_DT schemes_NNS assets_NNS are_VBP not_RB intended_VBN to_TO be_VB realized_VBN in_IN the_DT short_JJ term_NN and_CC may_MD be_VB subject_JJ to_TO significant_JJ change_NN before_IN they_PRP are_VBP realized_VBN ._.
The_DT present_JJ value_NN of_IN the_DT schemes_NNS liabilities_NNS is_VBZ derived_VBN from_IN cash_NN flow_NN projections_NNS over_IN long_JJ periods_NNS and_CC are_VBP thus_RB inherently_RB uncertain_JJ ._.
If_IN FRS_NNP 17_CD had_VBD been_VBN adopted_VBN for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2003_CD ,_, the_DT Groups_NNS reported_VBD net_JJ assets_NNS see_VBP page_NN 64_CD would_MD be_VB reduced_VBN by_IN $_$ 1,057_CD m_NN 7.9_CD %_NN to_TO $_$ 12,200_CD m._NN Further_JJ explanation_NN of_IN this_DT adjustment_NN is_VBZ included_VBN below_IN :_: Value_NN at_IN 31_CD December_NNP 2003_CD Value_NN at_IN 31_CD December_NNP 2002_CD Rest_VB of_IN Rest_VB of_IN UK_NNP Group_NNP Total_NNP UK_NNP Group_NNP Total_NNP $_$ m_CD $_$ m_CD $_$ m_CD $_$ m_CD $_$ m_CD $_$ m_CD Scheme_NN assets_NNS Equities_NNS 1,779_CD 1,157_CD 2,936_CD 1,186_CD 708_CD 1,894_CD Bonds_NNS 2,430_CD 485_CD 2,915_CD 2,097_CD 464_CD 2,561_CD Others_NNS 109_CD 74_CD 183 75 102 177_CD Total_JJ fair_JJ value_NN of_IN assets_NNS 4,318_CD 1,716_CD 6,034_CD 3,358_CD 1,274_CD 4,632_CD Present_JJ value_NN of_IN scheme_NN liabilities_NNS 5,232_CD 2,115_CD 7,347_CD 4,200_CD 1,665_CD 5,865_CD Deficit_NN in_IN the_DT scheme_NN 914_CD 399_CD 1,313_CD 842_CD 391_CD 1,233_CD Related_VBN deferred_VBN tax_NN asset_NN 274 156 430 253_CD 151_CD 404_CD Net_JJ post-retirement_JJ deficit_NN under_IN FRS_NNP 17 640 243 883_CD 589 240 829_CD Adjustments_NNS for_IN assets_NNS and_CC provisions_NNS under_IN SSAP_NNP 24_CD Prepayment_NN ,_, net_NN of_IN related_JJ deferred_JJ tax_NN 203 203 406_CD 70 107 177_CD Accrual_NNP ,_, net_NN of_IN deferred_JJ tax_NN 19_CD 58_CD 77_CD 36_CD 36_CD Provision_NNP ,_, net_NN of_IN deferred_JJ tax_NN 155_CD 155 12 116 128_CD Adjusted_VBN post-retirement_JJ deficit_NN ,_, net_NN of_IN related_JJ deferred_JJ tax_NN 824_CD 233_CD 1,057_CD 647 195 842_CD Net_JJ assets_NNS as_IN currently_RB disclosed_VBN see_VBP page_NN 64_CD 13,257_CD 11,226_CD Net_JJ assets_NNS as_IN adjusted_VBN if_IN FRS_NNP 17_CD were_VBD fully_RB adopted_VBN 12,200_CD 10,384_CD The_DT present_JJ value_NN of_IN the_DT UK_NNP schemes_NNS liabilities_NNS has_VBZ increased_VBN to_TO $_$ 5,232_CD m_NN from_IN $_$ 4,200_CD m_NN in_IN 2002_CD ._.
This_DT increase_NN has_VBZ been_VBN driven_VBN in_IN part_NN by_IN the_DT changes_NNS in_IN financial_JJ assumptions_NNS detailed_VBN on_IN page_NN 91_CD ._.
There_EX has_VBZ also_RB been_VBN an_DT adverse_JJ exchange_NN effect_NN of_IN approximately_RB $_$ 320m_CD on_IN these_DT liabilities_NNS during_IN the_DT year_NN ._.
AstraZeneca_NNP Annual_JJ Report_NNP and_CC Financial_NNP Statements_NNP Form_NN 20-F_NNP Information_NNP 2003_CD 93_CD 29_CD Post-retirement_NN benefits_NNS continued_VBD Profit_NN and_CC loss_NN account_NN disclosures_NNS On_IN full_JJ compliance_NN with_IN FRS_NNP 17_CD ,_, on_IN the_DT basis_NN of_IN the_DT above_JJ assumptions_NNS ,_, the_DT amounts_NNS that_WDT would_MD have_VB been_VBN charged_VBN to_TO the_DT consolidated_JJ profit_NN and_CC loss_NN account_NN and_CC statement_NN of_IN total_JJ recognized_VBN gains_NNS and_CC losses_NNS ,_, in_IN respect_NN of_IN defined_VBN benefit_NN schemes_NNS for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2003_CD are_VBP set_VBN out_RP below_IN :_: 2003_CD 2002_CD Rest_VB of_IN Rest_VB of_IN UK_NNP Group_NNP Total_NNP UK_NNP Group_NNP Total_NNP $_$ m_CD $_$ m_CD $_$ m_CD $_$ m_CD $_$ m_CD $_$ m_CD Operating_NN profit_NN Current_JJ service_NN cost_NN 110 88 198 100_CD 69_CD 169_CD Past_JJ service_NN costs_NNS 2_CD 8_CD 6_CD Settlement_NNP and_CC curtailment_NN 24_CD 24_CD Total_JJ operating_VBG charge_NN 110 88 198 102_CD 37_CD 139_CD Finance_NNP expense_NN Expected_VBN return_NN on_IN post-retirement_JJ scheme_NN assets_NNS 211 87 298 197_CD 52_CD 249_CD Interest_NN on_IN post-retirement_JJ scheme_NN liabilities_NNS 239 108 347 210_CD 98_CD 308_CD Net_JJ return_NN 28_CD 21_CD 49_CD 13_CD 46_CD 59_CD Loss_NN before_IN taxation_NN 138 109 247 115_CD 83_CD 198_CD Consolidated_NNP statement_NN of_IN total_JJ recognized_VBN gains_NNS and_CC losses_NNS Actual_JJ return_NN less_RBR expected_JJ return_NN on_IN the_DT post-retirement_JJ schemes_NNS assets_NNS 210 86 296 301_CD 91_CD 392_CD Experience_NN losses_NNS gains_VBZ arising_VBG on_IN the_DT post-retirement_JJ schemes_NNS liabilities_NNS 6_CD 33_CD 39_CD 108_CD 8_CD 100_CD Changes_NNS in_IN assumptions_NNS underlying_VBG the_DT present_JJ value_NN of_IN the_DT post-retirement_JJ schemes_NNS liabilities_NNS 350 116 466_CD 58_CD 27_CD 31_CD Actuarial_JJ loss_NN recognized_VBN 146 63 209 351_CD 110_CD 461_CD AstraZeneca_NNP Annual_JJ Report_NNP and_CC Financial_NNP Statements_NNP 94_CD Form_NN 20-F_JJ Information_NN 2003_CD Notes_NNS to_TO the_DT Financial_NNP Statements_NNP continued_VBD 29_CD Post-retirement_NN benefits_NNS continued_VBD Additional_JJ disclosures_NNS for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2003 2003 2002_CD Rest_VB of_IN Rest_VB of_IN UK_NNP Group_NNP Total_NNP UK_NNP Group_NNP Total_NNP $_$ m_CD $_$ m_CD $_$ m_CD $_$ m_CD $_$ m_CD $_$ m_CD Difference_NN between_IN the_DT expected_VBN and_CC actual_JJ return_NN on_IN scheme_NN assets_NNS :_: Amount_NNP 210 86 296 301_CD 91_CD 392_CD Percentage_NN of_IN scheme_NN assets_NNS 4.9_CD %_NN 5.0_CD %_NN 4.9_CD %_NN 9.0_CD %_NN 7.1_CD %_NN 8.5_CD %_NN Experience_NN gains_NNS and_CC losses_NNS on_IN scheme_NN liabilities_NNS :_: Amount_NNP 6_CD 33_CD 39_CD 108_CD 8_CD 100_CD Percentage_NN of_IN the_DT present_JJ value_NN of_IN scheme_NN liabilities_NNS 0.1_CD %_NN 1.6_CD %_NN 0.5_CD %_NN 2.6_CD %_NN 0.5_CD %_NN 1.7_CD %_NN Total_JJ amount_NN recognized_VBN in_IN statement_NN of_IN total_JJ recognized_VBN gains_NNS and_CC losses_NNS :_: Amount_NNP 146 63 209 351_CD 110_CD 461_CD Percentage_NN of_IN the_DT present_JJ value_NN of_IN scheme_NN liabilities_NNS 2.8_CD %_NN 3.0_CD %_NN 2.8_CD %_NN 8.4_CD %_NN 6.6_CD %_NN 7.9_CD %_NN Movement_NNP in_IN post-retirement_JJ scheme_NN deficit_NN during_IN the_DT year_NN ended_VBD 31_CD December_NNP 2003 2003 2002_CD Rest_VB of_IN Rest_VB of_IN UK_NNP Group_NNP Total_NNP UK_NNP Group_NNP Total_NNP $_$ m_CD $_$ m_CD $_$ m_CD $_$ m_CD $_$ m_CD $_$ m_CD Deficits_NNS in_IN schemes_NNS at_IN beginning_NN of_IN the_DT year_NN 842_CD 391_CD 1,233_CD 424_CD 718_CD 1,142_CD Current_JJ service_NN cost_NN 110 88 198 100_CD 69_CD 169_CD Contributions_NNS 299 207 506 125_CD 567_CD 692_CD Past_JJ service_NN cost_NN 2_CD 8_CD 6_CD Settlement_NNP and_CC curtailment_NN 24_CD 24_CD Other_JJ finance_NN income_NN 28_CD 21_CD 49_CD 13_CD 46_CD 59_CD Actuarial_JJ loss_NN 146 63 209 351_CD 110_CD 461_CD Exchange_NNP 87_CD 43_CD 130_CD 77_CD 47_CD 124_CD Deficits_NNS in_IN schemes_NNS at_IN end_NN of_IN the_DT year_NN 914_CD 399_CD 1,313_CD 842_CD 391_CD 1,233_CD Adjusted_VBN post-retirement_JJ deficit_NN ,_, net_NN of_IN deferred_JJ tax_NN 1,057_CD 842_CD The_DT increase_NN in_IN the_DT deficit_NN during_IN 2003_CD reflects_VBZ changes_NNS in_IN assumptions_NNS in_IN calculating_VBG liabilities_NNS principally_RB in_IN the_DT UK_NNP funds_NNS and_CC exchange_NN movements_NNS offset_VBN by_IN contributions_NNS made_VBN to_TO the_DT funds_NNS and_CC better_JJR actual_JJ returns_NNS on_IN plan_NN assets_NNS than_IN expected_VBN ._.
Reserves_NNS note_VBP for_IN the_DT year_NN ended_VBD 31_CD December_NNP 2003 2003 2002_CD Total_JJ Total_JJ $_$ m_CD $_$ m_CD Profit_NN and_CC loss_NN reserve_NN excluding_VBG post-retirement_JJ liability_NN 10,449_CD 8,451_CD Post-retirement_NN reserve_NN 1,057_CD 842_CD Profit_NN and_CC loss_NN reserve_NN under_IN FRS17_NNP 9,392_CD 7,609_CD
